On February 21, 2024, Adverum Biotechnologies, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.61 USD | -2.04% | -3.90% | +27.66% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.66% | 199M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.18% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Adverum Biotechnologies, Inc. announced that it has received $127.5 million in funding from a group of investors